---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-109777"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T12:16:45.963408+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Medical Group announces $250M share repurchase program with three-year term

## Summary
- Board authorized up to $250M in share repurchases of outstanding common stock over three years.
- CEO Mark Ordan cites strong cash flow, current cash balances, and low debt levels as rationale.
- Repurchases may be made via open market or privately negotiated transactions, including 10b5-1 plans.
- Program may be suspended or discontinued at any time; no obligation to repurchase any specific amount.
- Company will weigh repurchases against other strategic uses of cash for long-term shareholder returns.

## SEC filing metadata
- accession: 0000950170-25-109777
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017025109777/0000950170-25-109777-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017025109777/md-20250818.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-109777
- JSON: https://secwatch.observer/filing/0000950170-25-109777.json
- Plain text: https://secwatch.observer/filing/0000950170-25-109777.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.